Zhong Guo Jing Ji Wang·2025-10-23 09:06Core Points - Huiyu Pharmaceutical (688553.SH) closed at 21.28 yuan, with a decline of 2.96%, currently in a state of breaking issue [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 26, 2021, with an initial public offering (IPO) of 63.6 million shares at a price of 38.87 yuan per share [1] - On the first day of trading, the stock reached a peak of 42.59 yuan, marking the highest price since its listing [1] Fundraising and Financials - Huiyu Pharmaceutical raised a total of 2.472 billion yuan through the IPO, with a net amount of 2.361 billion yuan after deducting issuance costs [1] - The net fundraising amount exceeded the original plan by 453 million yuan [1] - The company intended to use the funds for the construction of the EU-standard injection production base (Phase II), the establishment of an innovative drug research institute, and to supplement working capital [1] - Total issuance costs amounted to 111 million yuan, with underwriting fees to CITIC Securities and Guodu Securities totaling 98.875 million yuan [1]